XBiotech Inc.

XBiotech Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
35.82 M
Public Float
25.01 M
XBiotech Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.64
Market Cap
$318.27 M
Shares Outstanding
40.96 M
Public Float
13.14 M

Profile

Address
5217 Winnebago Lane
Austin Texas 78744
United States
Employees -
Website http://www.xbiotech.com
Updated 07/08/2019
XBiotech, Inc. is a biopharmaceutical company, which engages in discovering and developing True Human monoclonal antibodies for treating diseases. It offers MABp1, which targets and neutralizes interleukin-1 alpha, a molecule known to promote angiogenesis, growth and spread of tumors, as well as mediate symptoms such as metabolic dysregulation, fatigue, and anxiety associated with advanced cancer. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.

Financials

View All

John Simard
Chairman, President & Chief Executive Officer
Donald H. MacAdam
Independent Director